Life-saving effect of pulmonary surfactant in premature babies

J Usha Raj1, Richard D Bland2, Jahar Bhattacharya3

  • 1Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA.

Insights

The discovery and replacement of lung surfactant improve survival for premature infants with respiratory distress syndrome. This advancement offers critical support for extremely premature newborns.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Biochemistry

Background:

  • Neonatal respiratory distress syndrome (RDS) is a significant cause of mortality in extremely premature infants.
  • Immature lungs in premature neonates often lack sufficient pulmonary surfactant, leading to alveolar collapse and impaired gas exchange.

Observation:

  • Pulmonary surfactant is a complex mixture of lipids and proteins essential for reducing surface tension in the alveoli.
  • Deficiency or dysfunction of lung surfactant is a primary factor in the pathophysiology of RDS.

Findings:

  • The development and clinical application of exogenous lung surfactant replacement therapy have been pivotal.
  • Administration of artificial or natural surfactant directly into the airways of affected infants improves lung compliance and oxygenation.

Implications:

  • Surfactant therapy has dramatically improved survival rates for extremely premature infants diagnosed with RDS.
  • Continued research into optimal surfactant formulations and delivery methods may further enhance outcomes and reduce long-term respiratory morbidities.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.2K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136